Abstract
Diabetes mellitus is a chronic disease affecting glucose metabolism. The pathophysiological reactions underpinning the disease can lead to the development of late diabetes complications. The gut microbiota plays important roles in weight regulation and the maintenance of a healthy digestive system. Obesity, diabetes mellitus, diabetic retinopathy, diabetic nephropathy and diabetic neuropathy are all associated with a microbial imbalance in the gut. Modern technical equipment and advanced diagnostic procedures, including xmolecular methods, are commonly used to detect both quantitative and qualitative changes in the gut microbiota. This review summarises collective knowledge on the role of the gut microbiota in both types of diabetes mellitus and their late complications, with a particular focus on diabetic foot syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abell GCJ, Cooke CM, Bennett CN, Conlon MA, McOrist AL (2008) Phylotypes related to Ruminococcus bromii are abundant in the large bowel of humans and increase in response to a diet high in resistant starch. FEMS Microbiol Ecol 66:505–515. https://doi.org/10.1111/J.1574-6941.2008.00527.X
Akash MSH, Rehman K, Fiayyaz F, Sabir S (2020) Khurshid M (2020) Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies. Arch Microbiol 2025(202):953–965. https://doi.org/10.1007/S00203-020-01818-X
Alang N, Kelly CR (2015) Weight gain after fecal microbiota transplantation. Open Forum Infect Dis 2. https://doi.org/10.1093/OFID/OFV004
Alcántara C, Sarmiento-Rubiano LA, Monedero V, Deutscher J, Pérez-Martínez G, Yebra MJ (2008) Regulation of Lactobacillus casei sorbitol utilization genes requires DNA-binding transcriptional activator GutR and the conserved protein GutM. Appl Environ Microbiol 74:5731–5740. https://doi.org/10.1128/AEM.00230-08
Alkanani AK, Hara N, Gottlieb PA, Ir D, Robertson CE, Wagner BD, Frank DN, Zipris D (2015) Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes 64:3510–3520. https://doi.org/10.2337/DB14-1847
Allin KH, Tremaroli V, Caesar R, Jensen BAH, Damgaard MTF, Bahl MI, Licht TR, Hansen TH, Nielsen T, Dantoft TM, Linneberg A, Jørgensen T, Vestergaard H, Kristiansen K, Franks PW, Hansen T, Bäckhed F, Pedersen O (2018) Aberrant intestinal microbiota in individuals with prediabetes. Diabetologia 61:810–820. https://doi.org/10.1007/S00125-018-4550-1
Almeida A, Mitchell AL, Boland M, Forster SC, Gloor GB, Tarkowska A, Lawley TD, Finn RD (2019) A new genomic blueprint of the human gut microbiota. Nature 568:499–504. https://doi.org/10.1038/s41586-019-0965-1
Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K (2021) Metabolism and metabolic disorders and the microbiome: the intestinal microbiota associated with obesity, lipid metabolism, and metabolic health—pathophysiology and therapeutic strategies. Gastroenterology 160:573–599. https://doi.org/10.1053/J.GASTRO.2020.10.057
Arumugam M, Raes J, Pelletier E, Le PD, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Doré J, Weissenbach J, Ehrlich SD, Bork P, Antolín M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Kristiansen K, Lakhdari O, Layec S, Le RK, Maguin E, Mérieux A, Minardi RM, M’rini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G (2011) Enterotypes of the human gut microbiome. Nature 473:174–180. https://doi.org/10.1038/nature09944
Arya M, Shergill IS, Williamson M, Gommersall L, Arya N, Patel HRH (2005) Basic principles of real-time quantitative PCR. Expert Rev Mol Diagn 5:209–219. https://doi.org/10.1586/14737159.5.2.209
Asghari G, Farhadnejad H, Teymoori F, Mirmiran P, Tohidi M, Azizi F (2018) High dietary intake of branched-chain amino acids is associated with an increased risk of insulin resistance in adults. J Diabetes 10:357–364. https://doi.org/10.1111/1753-0407.12639
Athanasopoulou K, Boti MA, Adamopoulos PG, Skourou PC, Scorilas A (2022) Third-generation sequencing: the spearhead towards the radical transformation of modern genomics. Life 30(12):30. https://doi.org/10.3390/LIFE12010030
Aybar JNA, Mayor SO, Olea L, Garcia JJ, Nisoria S, Kolling Y, Melian C, Rachid M, Dimani RT, Werenitzky C, Lorca C, Salva S, Gobbato N, Villena J, Valdez JC (2022) Topical administration of Lactiplantibacillus plantarum accelerates the healing of chronic diabetic foot ulcers through modifications of infection, angiogenesis, macrophage phenotype and neutrophil response. Microorganisms 10:634. https://doi.org/10.3390/microorganisms10030634
Ayivi RD, Gyawali R, Krastanov A, Aljaloud SO, Worku M, Tahergorabi R, da Silva RC (2020) Ibrahim SA (2020) Lactic acid bacteria: food safety and human health applications. Dairy 1(1):202–232. https://doi.org/10.3390/DAIRY1030015
Bai J, Wan Z, Zhang Y, Wang T, Xue Y, Peng Q (2022) Composition and diversity of gut microbiota in diabetic retinopathy. Front Microbiol 13:3267. https://doi.org/10.3389/FMICB.2022.926926
Barrios C, Beaumont M, Pallister T, Villar J, Goodrich JK, Clark A, Pascual J, Ley RE, Spector TD, Bell JT, Menni C (2015) Gut-microbiota-metabolite axis in early renal function decline. PLoS One 10. https://doi.org/10.1371/JOURNAL.PONE.0134311
Belkaid Y, Hand TW (2014) Role of the microbiota in immunity and inflammation. Cell 157:121–141. https://doi.org/10.1016/j.cell.2014.03.011
Biassoni R, Di Marco E, Squillario M, Barla A, Piccolo G, Ugolotti E, Gatti C, Minuto N, Patti G, Maghnie M, d’Annunzio G (2020) Gut microbiota in T1DM-onset pediatric patients: machine-learning algorithms to classify microorganisms as disease linked. J Clin Endocrinol Metab 105:e3114–e3126. https://doi.org/10.1210/CLINEM/DGAA407
Bielka W, Przezak A, Pawlik A (2022) The role of the gut microbiota in the pathogenesis of diabetes. Int J Mol Sci 23:480. https://doi.org/10.3390/IJMS23010480
Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, Casella G, Drew JC, Ilonen J, Knip M, Hyöty H, Veijola R, Simell T, Simell O, Neu J, Wasserfall CH, Schatz D, Atkinson MA, Triplett EW (2011) Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE 6:1–9. https://doi.org/10.1371/journal.pone.0025792
Buffie CG, Pamer EG (2013) Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13:790–801. https://doi.org/10.1038/nri3535
Bumgarner R (2013) Overview of DNA microarrays: types, applications, and their future. Curr Protoc Mol Biol 6137:1–17. https://doi.org/10.1002/0471142727.mb2201s101
Burcelin R (2016) Gut microbiota and immune crosstalk in metabolic disease. Mol Metab 5:771–781. https://doi.org/10.1016/J.MOLMET.2016.05.016
Cabral-de-Mello DC, Martins C (2010) Breaking down the genome organization and karyotype differentiation through the epifluorescence microscope lens: insects and fish as models
Caesar R, Tremaroli V, Kovatcheva-Datchary P, Cani PD, Bäckhed F (2015) Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab 22:658–668. https://doi.org/10.1016/J.CMET.2015.07.026
Cai K, Ma Y, Cai F, Huang X, Xiao L, Zhong C, Ren P, Luo Q, Chen J, Han F (2022) Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury. Endocrine 76:294–303. https://doi.org/10.1007/s12020-022-03002-1
Campos LF, Tagliari E, Casagrande TAC, de Noronha L, Campos ACL, Matias JEF (2020) Effects of probiotics supplementation on skin wound healing in diabetic rats. ABCD Arq Bras Cir Dig (são Paulo) 33:e1498. https://doi.org/10.1590/0102-672020190001E1498
Canchy L, Kerob D, Demessant A, Amici JM (2023) Wound healing and microbiome, an unexpected relationship. J Eur Acad Dermatology Venereol 37:7–15. https://doi.org/10.1111/JDV.18854
Cani PD, Delzenne NM (2007) Current opinion in clinical nutrition and metabolic care. Wolters Kluwer Health | Lippincott Williams & Wilkins
Caricilli AM, Saad MJA (2013) The role of gut microbiota on insulin resistance. Nutrients 5:829–851. https://doi.org/10.3390/nu5030829
Carvalho-Filho MA, Ueno M, Hirabara SM, Seabra AB, Carvalheira JBC, De Oliveira MG, Velloso LA, Curi R, Saad MJA (2005) S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 54:959–967. https://doi.org/10.2337/DIABETES.54.4.959
Castillo CR, Alishahedani ME, Gough P, Chaudhary PP, Yadav M, Matriz J, Myles IA (2021) Assessing the effects of common topical exposures on skin bacteria associated with atopic dermatitis. Ski Heal Dis 1:e41. https://doi.org/10.1002/SKI2.41
Chassard C, Lacroix C (2013) Carbohydrates and the human gut microbiota. Curr Opin Clin Nutr Metab Care 16:453–460. https://doi.org/10.1097/MCO.0B013E3283619E63
Chassard C, Goumy V, Leclerc M, Del’homme C, Bernalier-Donadille A, (2007) Characterization of the xylan-degrading microbial community from human faeces. FEMS Microbiol Ecol 61:121–131. https://doi.org/10.1111/J.1574-6941.2007.00314.X
Chen S, Henderson A, Petriello MC, Romano KA, Gearing M, Miao J, Schell M, Sandoval-Espinola WJ, Tao J, Sha B, Graham M, Crooke R, Kleinridders A, Balskus EP, Rey FE, Morris AJ, Biddinger SB (2019) Trimethylamine N-oxide binds and activates PERK to promote metabolic dysfunction. Cell Metab 30:1141-1151.e5. https://doi.org/10.1016/J.CMET.2019.08.021
Chen S, Han P, Zhang Q, Liu P, Liu J, Zhao L, Guo L, Li J (2023) Lactobacillus brevis alleviates the progress of hepatocellular carcinoma and type 2 diabetes in mice model via interplay of gut microflora, bile acid and NOTCH 1 signaling. Front Immunol 14:1179014. https://doi.org/10.3389/FIMMU.2023.1179014
Choundappan M (2017) Probiotics in diabetic wound care. Madras Medical College
Chung S, LaPoint K, Martinez K, Kennedy A, Sandberg MB, McIntosh MK (2006) Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147:5340–5351. https://doi.org/10.1210/EN.2006-0536
Cinek O, Kramna L, Mazankova K, Odeh R, Alassaf A, Ibekwe MAU, Ahmadov G, Elmahi BME, Mekki H, Lebl J, Abdullah MA (2018) The bacteriome at the onset of type 1 diabetes: a study from four geographically distant African and Asian countries. Diabetes Res Clin Pract 144:51–62. https://doi.org/10.1016/J.DIABRES.2018.08.010
Claesson MJ, Jeffery IB, Conde S, Power SE, O’Connor EM, Cusack S, Harris HMB, Coakley M, Lakshminarayanan B, O’Sullivan O, Fitzgerald GF, Deane J, O’Connor M, Harnedy N, O’Connor K, O’Mahony D, Van Sinderen D, Wallace M, Brennan L, Stanton C, Marchesi JR, Fitzgerald AP, Shanahan F, Hill C, Paul Ross R, O’Toole PW (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488:178–184. https://doi.org/10.1038/NATURE11319
Constantino-Jonapa LA, Espinoza-Palacios Y, Escalona-Montaño AR, Hernández-Ruiz P, Amezcua-Guerra LM, Amedei A, Aguirre-García MM (2023) Contribution of trimethylamine N-oxide (TMAO) to chronic inflammatory and degenerative diseases. Biomed 431(11):431. https://doi.org/10.3390/BIOMEDICINES11020431
Cox LM, Blaser MJ (2015) Antibiotics in early life and obesity. Nat Rev Endocrinol 11:182–190. https://doi.org/10.1038/nrendo.2014.210
Cresci GA, Bawden E (2015) Gut microbiome: what we do and don’t know. Nutr Clin Pract 30:734–746. https://doi.org/10.1177/0884533615609899
Cryan JF (2012) Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 1310(13):701–712. https://doi.org/10.1038/nrn3346
Cunningham AL, Stephens JW, Harris DA (2021b) Gut microbiota influence in type 2 diabetes mellitus (T2DM). Gut Pathog 13:1–13. https://doi.org/10.1186/s13099-021-00446-0
Cunningham AL, Stephens JW, Harris DA (2021a) A review on gut microbiota: a central factor in the pathophysiology of obesity. Lipids Health Dis 20:. https://doi.org/10.1186/S12944-021-01491-Z
David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ (2013) Turnbaugh PJ (2013) Diet rapidly and reproducibly alters the human gut microbiome. Nat 5057484(505):559–563. https://doi.org/10.1038/nature12820
De Clercq NC, Frissen MN, Davids M, Groen AK, Nieuwdorp M (2019) Weight gain after fecal microbiota transplantation in a patient with recurrent underweight following clinical recovery from anorexia nervosa. Psychother Psychosom 88:58–60. https://doi.org/10.1159/000495044
De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107:14691–14696. https://doi.org/10.1073/PNAS.1005963107
De Goffau MC, Luopajärvi K, Knip M, Ilonen J, Ruohtula T, Härkönen T, Orivuori L, Hakala S, Welling GW, Harmsen HJ, Vaarala O (2013) Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 62:1238–1244. https://doi.org/10.2337/db12-0526
Degruttola AK, Low D, Mizoguchi A, Mizoguchi E (2016) Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis 22:1137. https://doi.org/10.1097/MIB.0000000000000750
Del Chierico F, Rapini N, Deodati A, Matteoli MC, Cianfarani S, Putignani L (2022) Pathophysiology of type 1 diabetes and gut microbiota role. Int J Mol Sci 23:14650. https://doi.org/10.3390/IJMS232314650
DeMartino P, Cockburn DW (2020) Resistant starch: impact on the gut microbiome and health. Curr Opin Biotechnol 61:66–71. https://doi.org/10.1016/J.COPBIO.2019.10.008
Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Genet 6:e280. https://doi.org/10.1371/journal.pbio.0060280
Dongowski G, Lorenz A, Anger H (2000) Degradation of pectins with different degrees of esterification by Bacteroides thetaiotaomicron isolated from human gut flora. Appl Environ Microbiol 66:1321. https://doi.org/10.1128/AEM.66.4.1321-1327.2000
Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE (2007) Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 73:1073–1078. https://doi.org/10.1128/AEM.02340-06
Egshatyan L, Kashtanova D, Popenko A, Tkacheva O, Tyakht A, Alexeev D, Karamnova N, Kostryukova E, Babenko V, Vakhitova M, Boytsov S (2016) Gut microbiota and diet in patients with different glucose tolerance. Endocr Connect 5:1–9. https://doi.org/10.1530/EC-15-0094
Eiselein L, Schwartz HJ, Rutledge JC (2004) The challenge of type 1 diabetes mellitus. ILAR J 45:231–236. https://doi.org/10.1093/ILAR.45.3.231
Eisenbarth GS (2007) Update in type 1 diabetes. J Clin Endocrinol Metab 92:2403–2407. https://doi.org/10.1210/JC.2007-0339
Elvers KT, Wilson VJ, Hammond A, Duncan L, Huntley AL, Hay AD, van der Werf ET (2020) Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review. BMJ Open 10:e035677. https://doi.org/10.1136/BMJOPEN-2019-035677
Endesfelder D, Castell WZ, Ardissone A, Davis-Richardson AG, Achenbach P, Hagen M, Pflueger M, Gano KA, Fagen JR, Drew JC, Brown CT, Kolaczkowski B, Atkinson M, Schatz D, Bonifacio E, Triplett EW, Ziegler AG (2014) Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 63:2006–2014. https://doi.org/10.2337/DB13-1676
Erem C, Hacihasanoǧlu A, Çelik Ş, Ovali E, Önder Ersöz H, Ukinç K, Deger O, Telatar M (2005) Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. Med Princ Pract 14:22–30. https://doi.org/10.1159/000081919
Fejfarová V, Jarošíková R, Polák J, Sommerová B, Husáková J, Wosková V, Dubský M, Tůma P (2023) Microdialysis as a tool for antibiotic assessment in patients with diabetic foot: a review. Front Endocrinol (lausanne) 14:1141086. https://doi.org/10.3389/FENDO.2023.1141086/BIBTEX
Fejfarová V, Jirkovská A, Dubský M, Game F, Vydláková J, Sekerková A, Franeková J, Kučerová M, Stříž I, Petkov V, Bém R, Wosková V, Němcová A, Skibová J (2016) An alteration of lymphocytes subpopulations and immunoglobulins levels in patients with diabetic foot ulcers infected particularly by resistant pathogens. J Diabetes Res 2016:. https://doi.org/10.1155/2016/2356870
Fenneman AC, Weidner M, Chen LA, Nieuwdorp M (2022) Blaser MJ (2022) Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 202(20):81–100. https://doi.org/10.1038/s41575-022-00685-9
Fiaccadori E, Cosola C, Sabatino A (2020) Targeting the gut for early diagnosis, prevention, and cure of diabetic kidney disease: is the phenyl sulfate story another step forward? Am J Kidney Dis 75:144–147. https://doi.org/10.1053/J.AJKD.2019.07.001
Fijan S, Frauwallner A, Langerholc T, Krebs B, Ter Haar JA, Heschl A, Mičetić Turk D, Rogelj I (2019) Efficacy of using probiotics with antagonistic activity against pathogens of wound infections: an integrative review of literature. Biomed Res Int 2019:. https://doi.org/10.1155/2019/7585486
Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Prifti E, Vieira-Silva S, Gudmundsdottir V, Krogh Pedersen H, Arumugam M, Kristiansen K, Yvonne Voigt A, Vestergaard H, Hercog R, Igor Costea P, Roat Kultima J, Li J, Jørgensen T, Levenez F, Dore J, Bjørn Nielsen H, Brunak S, Raes J, Hansen T, Wang J, Dusko Ehrlich S, Bork P, Pedersen O (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528:262–266. https://doi.org/10.1038/NATURE15766
Fraher MH, O’Toole PW, Quigley EMM (2012) Techniques used to characterize the gut microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol 9:312–322. https://doi.org/10.1038/nrgastro.2012.44
Fu J, Bonder MJ, Cenit MC, Tigchelaar EF, Maatman A, Dekens JAM, Brandsma E, Marczynska J, Imhann F, Weersma RK, Franke L, Poon TW, Xavier RJ, Gevers D, Hofker MH, Wijmenga C, Zhernakova A (2015) The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ Res 117:817–824. https://doi.org/10.1161/CIRCRESAHA.115.306807/-/DC1
Fukuda S, Toh H, Taylor TD, Ohno H, Hattori M (2012) Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microbes 3:449–454. https://doi.org/10.4161/gmic.21214
Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, Mariat D, Corthier G, Doré J, Henegar C, Rizkalla S, Clément K (2010) Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59:3049–3057. https://doi.org/10.2337/db10-0253
Gao X, Liu X, Xu J, Xue C, Xue Y, Wang Y (2014) Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. J Biosci Bioeng 118:476–481. https://doi.org/10.1016/J.JBIOSC.2014.03.001
Gauffin Cano P, Santacruz A, Moya Á, Sanz Y (2012) Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PLoS ONE 7:e41079. https://doi.org/10.1371/JOURNAL.PONE.0041079
Ge X, Ge X, Zhang A, Zhang A, Li L, Li L, Sun Q, Sun Q, He J, He J, Wu Y, Wu Y, Tan R, Tan R, Pan Y, Pan Y, Zhao J, Zhao J, Xu Y, Xu Y, Tang H, Tang H, Gao Y, Gao Y (2022) Application of machine learning tools: potential and useful approach for the prediction of type 2 diabetes mellitus based on the gut microbiome profile. Exp Ther Med 23:1–10. https://doi.org/10.3892/ETM.2022.11234
Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV (2018) Knight R (2018) Current understanding of the human microbiome. Nat Med 244(24):392–400. https://doi.org/10.1038/nm.4517
Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, Drew JC, Ilonen J, Knip M, Hyöty H, Veijola R, Simell T, Simell O, Neu J, Wasserfall CH, Schatz D, Atkinson MA, Triplett EW (2011) Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 5:82–91. https://doi.org/10.1038/ismej.2010.92
Gomes A, Korf B (2017) Genetic testing techniques. Pediatr Cancer Genet 47–64. https://doi.org/10.1016/B978-0-323-48555-5.00005-3
Gowd V, Xie L, Zheng X, Chen W (2019) Dietary fibers as emerging nutritional factors against diabetes: focus on the involvement of gut microbiota. Crit Rev Biotechnol 39:524–540. https://doi.org/10.1080/07388551.2019.1576025
Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, Shulzhenko N (2020) Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine 51:102590. https://doi.org/10.1016/j.ebiom.2019.11.051
Haluzík M, Mráz M (2018) Intermittent fasting and prevention of diabetic retinopathy: where do we go from here? Diabetes 67:1745–1747. https://doi.org/10.2337/DBI18-0022
Han H, Li Y, Fang J, Liu G, Yin J, Li T, Yin Y (2018) Gut microbiota and type 1 diabetes. Int J Mol Sci 19:995. https://doi.org/10.3390/IJMS19040995
Heinsen FA, Knecht H, Neulinger SC, Schmitz RA, Knecht C, Kühbacher T, Rosenstiel PC, Schreiber S, Friedrichs AK, Ott SJ (2015) Dynamic changes of the luminal and mucosaassociated gut microbiota during and after antibiotic therapy with paromomycin. Gut Microbes 6:243–254. https://doi.org/10.1080/19490976.2015.1062959
Henneke L, Schlicht K, Andreani NA, Hollstein T, Demetrowitsch T, Knappe C, Hartmann K, Jensen-Kroll J, Rohmann N, Pohlschneider D, Geisler C, Schulte DM, Settgast U, Türk K, Zimmermann J, Kaleta C, Baines JF, Shearer J, Shah S, Shen-Tu G, Schwarz K, Franke A, Schreiber S, Laudes M (2022) A dietary carbohydrate – gut Parasutterella – human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes. Gut Microbes 14. https://doi.org/10.1080/19490976.2022.2057778
Hill MJ (1995) Bacterial fermentation of complex carbohydrate in the human colon. Eur J Cancer Prev 4:353–358. https://doi.org/10.1097/00008469-199510000-00004
Hobby GP, Karaduta O, Dusio GF, Singh M, Zybailov BL, Arthur JM (2019) Chronic kidney disease and the gut microbiome. Am J Physiol - Ren Physiol 316:F1211–F1217. https://doi.org/10.1152/ajprenal.00298.2018
Hollister EB, Gao C, Versalovic J (2014) Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology 146:1449. https://doi.org/10.1053/J.GASTRO.2014.01.052
Hong J, Fu T, Liu W, Du Y, Min C, Lin D (2022) Specific alterations of gut microbiota in diabetic microvascular complications: a systematic review and meta-analysis. Front Endocrinol (lausanne) 13:3074. https://doi.org/10.3389/FENDO.2022.1053900
Huon J-F, Montassier E, Leroy A-G, Grégoire M, Vibet M-A, Caillon J, Boutoille D, Navas D (2020) Phages versus antibiotics to treat infected diabetic wounds in a mouse model: a microbiological and microbiotic evaluation. mSystems 5. https://doi.org/10.1128/MSYSTEMS.00542-20
Ingrassia I, Leplingard A, Darfeuille-Michaud A (2005) Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn’s disease patients to adhere to and to invade intestinal epithelial cells. Appl Environ Microbiol 71:2880–2887
Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy DN (2015) Role of the normal gut microbiota. World J Gastroenterol 21:8836–8847. https://doi.org/10.3748/WJG.V21.I29.8787
Jernberg C, Löfmark S, Edlund C, Jansson JK (2010) Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156:3216–3223. https://doi.org/10.1099/mic.0.040618-0
Johanesen PA, Mackin KE, Hutton ML, Awad MM, Larcombe S, Amy JM, Lyras D (2015) Disruption of the gut microbiome: Clostridium difficile infection and the threat of antibiotic resistance. Genes (basel) 6:1347–1360. https://doi.org/10.3390/genes6041347
Jung DH, Kim GY, Kim IY, Seo DH, Do NY, Kang H, Song Y, Park CS (2019) Bifidobacterium adolescentis P2P3, a human gut bacterium having strong non-gelatinized resistant starch-degrading activity. J Microbiol Biotechnol 29:1904–1915. https://doi.org/10.4014/JMB.1909.09010
Kapur S, Picard F, Perreault M, Deshaies Y, Marette A (2000) Nitric oxide: a new player in the modulation of energy metabolism. Int J Obes 24:S36–S40. https://doi.org/10.1038/SJ.IJO.0801502
Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, Nielsen J, Bäckhed F (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498:99–103. https://doi.org/10.1038/nature12198
Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA (2017) Lernmark Å (2017) Type 1 diabetes mellitus. Nat Rev Dis Prim 31(3):1–17. https://doi.org/10.1038/nrdp.2017.16
Kawaguchi T, Izumi N, Charlton MR, Sata M (2011) Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology 54:1063–1070. https://doi.org/10.1002/HEP.24412
Kim J, Nam JH (2020) Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection. Int J Obes 44:1541–1542. https://doi.org/10.1038/s41366-020-0602-y
Kim YA, Keogh JB, Clifton PM (2018) Probiotics, prebiotics, synbiotics and insulin sensitivity. Nutr Res Rev 31:35–51. https://doi.org/10.1017/S095442241700018X
Konstantinidis T, Tsigalou C, Karvelas A, Stavropoulou E, Voidarou C, Bezirtzoglou E (2020) Effects of antibiotics upon the gut microbiome: a review of the literature. Biomedicines 8:1–15. https://doi.org/10.3390/biomedicines8110502
Koropatkin NM, Cameron EA (2012) Martens EC (2012) How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 105(10):323–335. https://doi.org/10.1038/nrmicro2746
Kostic AD, Gevers D, Siljander H, Vatanen T, Hyötyläinen T, Hämäläinen AM, Peet A, Tillmann V, Pöhö P, Mattila I, Lähdesmäki H, Franzosa EA, Vaarala O, De Goffau M, Harmsen H, Ilonen J, Virtanen SM, Clish CB, Orešič M, Huttenhower C, Knip M, Xavier RJ (2015) The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17:260–273. https://doi.org/10.1016/J.CHOM.2015.01.001
Kralik P, Ricchi M (2017) A basic guide to real time PCR in microbial diagnostics: definitions, parameters, and everything. Front Microbiol 8:1–9. https://doi.org/10.3389/fmicb.2017.00108
Kulkarni P, Devkumar P, Chattopadhyay I (2021) Could dysbiosis of inflammatory and anti-inflammatory gut bacteria have an implications in the development of type 2 diabetes? A pilot investigation. BMC Res Notes 14. https://doi.org/10.1186/S13104-021-05466-2
Lambeth SM, Carson T, Lowe J, Ramaraj T, Leff JW, Luo L, Bell CJ, Shah V (2015) Composition, diversity and abundance of gut microbiome in prediabetes and type 2 diabetes. J diabetes Obes 2:108–114. https://doi.org/10.15436/2376-0949.15.031
Lange K, Buerger M, Stallmach A, Bruns T (2016) Effects of antibiotics on gut microbiota. Dig Dis 34:260–268. https://doi.org/10.1159/000443360
Le TKC, Hosaka T, Nguyen TT, Kassu A, Dang TO, Tran HB, Pham TP, Tran QB, Le THH, Da Pham X (2015) Bifidobacterium species lower serum glucose, increase expressions of insulin signaling proteins, and improve adipokine profile in diabetic mice. Biomed Res 36:63–70. https://doi.org/10.2220/BIOMEDRES.36.63
Leiva-Gea I, Sánchez-Alcoholado L, Martín-Tejedor B, Castellano-Castillo D, Moreno-Indias I, Urda-Cardona A, Tinahones FJ, Fernández-García JC, Queipo-Ortuño MI (2018) Gut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: a case-control study. Diabetes Care 41:2385–2395. https://doi.org/10.2337/dc18-0253
Lemaitre RN, Jensen PN, Wang Z, Fretts AM, McKnight B, Nemet I, Biggs ML, Sotoodehnia N, De Oliveira Otto MC, Psaty BM, Siscovick DS, Hazen SL, Mozaffarian D (2021) Association of trimethylamine N-oxide and related metabolites in plasma and incident type 2 diabetes: the cardiovascular health study. JAMA Netw Open 4:e2122844–e2122844. https://doi.org/10.1001/JAMANETWORKOPEN.2021.22844
Li W-Z, Stirling K, Yang J-J, Zhang L, Yang J-J, Stirling K, Li W-Z, Stirling K, Yang J-J, Zhang L (2020) Gut microbiota and diabetes: from correlation to causality and mechanism. World J Diabetes 11:293–308. https://doi.org/10.4239/WJD.V11.I7.293
Li J, Yang G, Zhang Q, Liu Z, Jiang X, Xin Y (2023) Function of Akkermansia muciniphila in type 2 diabetes and related diseases. Front Microbiol 14:1172400. https://doi.org/10.3389/FMICB.2023.1172400/BIBTEX
Liu L, Zhang J, Cheng Y, Zhu M, Xiao Z, Ruan G, Wei Y (2022) Gut microbiota: a new target for T2DM prevention and treatment. Front Endocrinol (Lausanne) 13. https://doi.org/10.3389/FENDO.2022.958218
Lopez-Siles M, Khan TM, Duncan SH, Harmsen HJM, Garcia-Gil LJ, Flint HJ (2012) Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl Environ Microbiol 78:420–428. https://doi.org/10.1128/AEM.06858-11
Lotfy M, Adeghate J, Kalasz H, Singh J, Adeghate E (2017) Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev 13:3–10. https://doi.org/10.2174/1573399812666151016101622
Lu C (2019) chen, Hu Z bo, Wang R, Hong Z hui, Lu J, Chen P pei, Zhang J xiu, Li X qi, Yuan B yin, Huang S jia, Ruan X zhong, Liu B cheng, Ma K ling (2020) Gut microbiota dysbiosis-induced activation of the intrarenal renin–angiotensin system is involved in kidney injuries in rat diabetic nephropathy. Acta Pharmacol Sin 418(41):1111–1118. https://doi.org/10.1038/s41401-019-0326-5
Lynch SV, Pedersen O (2016) The human intestinal microbiome in health and disease. N Engl J Med 375:2369–2379. https://doi.org/10.1056/NEJMRA1600266
Maffeis C, Martina A, Corradi M, Quarella S, Nori N, Torriani S, Plebani M, Contreas G, Felis GE (2016) Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes. Diabetes Metab Res Rev 32:700–709. https://doi.org/10.1002/DMRR.2790
Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R (2020) The Firmicutes/Bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutr 2020, Vol 12. Page 1474(12):1474. https://doi.org/10.3390/NU12051474
Mangin I, Lévêque C, Magne F, Suau A, Pochart P (2012) Long-term changes in human colonic bifidobacterium populations induced by a 5-day oral amoxicillin-clavulanic acid treatment. PLoS ONE 7:2–10. https://doi.org/10.1371/journal.pone.0050257
Martel J, Chang SH, Ko YF, Hwang TL, Young JD, Ojcius DM (2022) Gut barrier disruption and chronic disease. Trends Endocrinol Metab 33:247–265. https://doi.org/10.1016/J.TEM.2022.01.002
Martínez-López YE, Esquivel-Hernández DA, Sánchez-Castañeda JP, Neri-Rosario D, Guardado-Mendoza R, Resendis-Antonio O (2022) Type 2 diabetes, gut microbiome, and systems biology: a novel perspective for a new era. 14. https://doi.org/10.1080/19490976.2022.2111952
Matey-Hernandez ML, Williams FMK, Potter T, Valdes AM, Spector TD, Menni C (2018) Genetic and microbiome influence on lipid metabolism and dyslipidemia. Physiol Genomics 50:117–126. https://doi.org/10.1152/PHYSIOLGENOMICS.00053.2017/ASSET
Mejía-León ME, Petrosino JF, Ajami NJ, Domínguez-Bello MG, De La Barca AMC (2014) Fecal microbiota imbalance in Mexican children with type 1 diabetes. Sci Rep 4:1–5. https://doi.org/10.1038/srep03814
Mikelsaar M (2011) Human microbial ecology: lactobacilli, probiotics, selective decontamination. Academic Press
Mohseni S, Bayani M, Bahmani F, Tajabadi-Ebrahimi M, Bayani MA, Jafari P, Asemi Z (2018) The beneficial effects of probiotic administration on wound healing and metabolic status in patients with diabetic foot ulcer: a randomized, double-blind, placebo-controlled trial. Diabetes Metab Res Rev 34. https://doi.org/10.1002/DMRR.2970
Mohtashami M, Mohamadi M, Azimi-Nezhad M, Saeidi J, Nia FF, Ghasemi A (2021) Lactobacillus bulgaricus and Lactobacillus plantarum improve diabetic wound healing through modulating inflammatory factors. Biotechnol Appl Biochem 68:1421–1431. https://doi.org/10.1002/BAB.2064
Mokhtari P, Metos J, Anandh Babu PV (2021) Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: possible mechanisms, current knowledge, and challenges. Gut Microbes 13:1–18
Monteiro-Soares M, Boyko EJ, Jeffcoate W, Mills JL, Russell D, Morbach S, Game F (2020) Diabetic foot ulcer classifications: a critical review. Diabetes Metab Res Rev 36:e3272. https://doi.org/10.1002/DMRR.3272
Mosca A, Leclerc M, Hugot JP (2016) Gut microbiota diversity and human diseases: should we reintroduce key predators in our ecosystem? Front Microbiol 7:178205. https://doi.org/10.3389/FMICB.2016.00455
Muñoz-Garach A, Diaz-Perdigones C, Tinahones FJ (2016) Gut microbiota and type 2 diabetes mellitus. Endocrinol y Nutr English (ed 63:560–568. https://doi.org/10.1016/J.ENDOEN.2016.07.004
Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, Queipo-Ortuño MI (2013) Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med 11:46. https://doi.org/10.1186/1741-7015-11-46
Nyavor Y, Brands CR, May G, Kuther S, Nicholson J, Tiger K, Tesnohlidek A, Yasuda A, Starks K, Litvinenko D, Linden DR, Bhattarai Y, Kashyap PC, Forney LJ, Balemba OB (2020) High-fat diet–induced alterations to gut microbiota and gut-derived lipoteichoic acid contributes to the development of enteric neuropathy. Neurogastroenterol Motil 32:e13838. https://doi.org/10.1111/NMO.13838
O’Neill CA, Monteleone G, McLaughlin JT, Paus R (2016) The gut-skin axis in health and disease: a paradigm with therapeutic implications. BioEssays 38:1167–1176. https://doi.org/10.1002/BIES.201600008
Owens RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA (2008) Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 46:19–31. https://doi.org/10.1086/521859
Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO (2007) Development of the human infant intestinal microbiota. PLoS Biol 5:1556–1573. https://doi.org/10.1371/journal.pbio.0050177
Papatheodorou K, Papanas N, Banach M, Papazoglou D, Edmonds M (2016) Complications of diabetes 2016. J Diabetes Res 2016. https://doi.org/10.1155/2016/6989453
Patel BK, Patel KH, Huang RY, Lee CN, Moochhala SM (2022) The gut-skin microbiota axis and its role in diabetic wound healing—a review based on current literature. Int J Mol Sci 23:2375. https://doi.org/10.3390/IJMS23042375
Payne AN, Chassard C, Lacroix C (2012) Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity. Obes Rev 13:799–809. https://doi.org/10.1111/J.1467-789X.2012.01009.X
Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BAH, Forslund K, Hildebrand F, Prifti E, Falony G, Le Chatelier E, Levenez F, Doré J, Mattila I, Plichta DR, Pöhö P, Hellgren LI, Arumugam M, Sunagawa S, Vieira-Silva S, Jørgensen T, Holm JB, Trošt K, Kristiansen K, Brix S, Raes J, Wang J, Hansen T, Bork P, Brunak S, Oresic M, Ehrlich SD (2016) Pedersen O (2016) Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 5357612(535):376–381. https://doi.org/10.1038/nature18646
Peng L, Li ZR, Green RS, Holzman IR, Lin J (2009) Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 139:1619–1625. https://doi.org/10.3945/JN.109.104638
Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, Baker CC, Di Francesco V, Howcroft TK, Karp RW, Lunsford RD, Wellington CR, Belachew T, Wright M, Giblin C, David H, Mills M, Salomon R, Mullins C, Akolkar B, Begg L, Davis C, Grandison L, Humble M, Khalsa J, Roger Little A, Peavy H, Pontzer C, Portnoy M, Sayre MH, Starke-Reed P, Zakhari S, Read J, Watson B, Guyer M (2009) The NIH Human Microbiome Project. Genome Res 19:2317–2323. https://doi.org/10.1101/GR.096651.109
Pourkazemi A, Ghanbari A, Khojamli M, Balo H, Hemmati H, Jafaryparvar Z, Motamed B (2020) Diabetic foot care: knowledge and practice. BMC Endocr Disord 20. https://doi.org/10.1186/S12902-020-0512-Y
Pradhan L, Nabzdyk C, Andersen ND, LoGerfo FW, Veves A (2009) Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med 11:e2. https://doi.org/10.1017/S1462399409000945
Prakash O, Pandey PK, Kulkarni GJ, Mahale KN, Shouche YS (2014) Technicalities and glitches of terminal restriction fragment length polymorphism (T-RFLP). Indian J Microbiol 54:255–261. https://doi.org/10.1007/s12088-014-0461-0
Prasad R, Asare-Bediko B, Harbour A, Floyd JL, Chakraborty D, Duan Y, Lamendella R, Wright J, Grant MB (2022) Microbial signatures in the rodent eyes with retinal dysfunction and diabetic retinopathy. Invest Ophthalmol vis Sci 63:5–5. https://doi.org/10.1167/IOVS.63.1.5
Qi CJ, Zhang Q, Yu M, Xu JP, Zheng J, Wang T, Xiao XH (2016) Imbalance of fecal microbiota at newly diagnosed type 1 diabetes in Chinese children. Chin Med J (engl) 129:1298–1304. https://doi.org/10.4103/0366-6999.182841
Qian X, Si Q, Lin G, Zhu M, Lu J, Zhang H, Wang G, Chen W (2022) Bifidobacterium adolescentis is effective in relieving type 2 diabetes and may be related to its dominant core genome and gut microbiota modulation capacity. Nutrients 14:2479
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li SSS, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li SSS, Jian M, Zhou Y, Li Y, Zhang X, Li SSS, Qin N, Yang H, Wang JJ, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD, Wang JJ, Antolin M, Artiguenave F, Blottiere H, Borruel N, Bruls T, Casellas F, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Forte M, Friss C, Van De Guchte M, Guedon E, Haimet F, Jamet A, Juste C, Kaci G, Kleerebezem M, Knol J, Kristensen M, Layec S, Le Roux K, Leclerc M, Maguin E, Melo Minardi R, Oozeer R, Rescigno M, Sanchez N, Tims S, Torrejon T, Varela E, De Vos W, Winogradsky Y, Zoetendal E (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65. https://doi.org/10.1038/nature08821
Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, Lechatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 4907418(490):55–60.https://doi.org/10.1038/nature11450
Rahman T, Sarwar PF, Potter C, Comstock SS, Klepac-Ceraj V (2023) Role of human milk oligosaccharide metabolizing bacteria in the development of atopic dermatitis/eczema. Front Pediatr 11:1090048. https://doi.org/10.3389/FPED.2023.1090048
Ramezani A, Massy ZA, Meijers B, Evenepoel P, Vanholder R, Raj DS (2016) Role of the gut microbiome in uremia: a potential therapeutic target. Am J Kidney Dis 67:483–498. https://doi.org/10.1053/J.AJKD.2015.09.027
Ratan ZA, Zaman S Bin, Mehta V, Haidere MF, Runa NJ, Akter N (2017) Application of fluorescence in situ hybridization (FISH) technique for the detection of genetic aberration in medical science. Cureus 9:. https://doi.org/10.7759/cureus.1325
Ribeiro CFA, Silveira GGDOS, Cândido EDS, Cardoso MH, Espínola Carvalho CM, Franco OL (2020) Effects of antibiotic treatment on gut microbiota and how to overcome its negative impacts on human health. ACS Infect Dis 6:2544–2559. https://doi.org/10.1021/ACSINFECDIS.0C00036
Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR, Muehlbauer MJ, Ilkayeva O, Semenkovich CF, Funai K, Hayashi DK, Lyle BJ, Martini MC, Ursell LK, Clemente JC, Van Treuren W, Walters WA, Knight R, Newgard CB, Heath AC, Gordon JI (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science (80- ) 341. https://doi.org/10.1126/science.1241214
Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, Mele MC (2019) What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7:14. https://doi.org/10.3390/microorganisms7010014
Rinninella E, Tohumcu E, Raoul P, Fiorani M, Cintoni M, Mele MC, Cammarota G, Gasbarrini A, Ianiro G (2023) The role of diet in shaping human gut microbiota. Best Pract Res Clin Gastroenterol 62–63:101828. https://doi.org/10.1016/J.BPG.2023.101828
Robert C, Bernalier-Donadille A (2003) The cellulolytic microflora of the human colon: evidence of microcrystalline cellulose-degrading bacteria in methane-excreting subjects. FEMS Microbiol Ecol 46:81–89. https://doi.org/10.1016/S0168-6496(03)00207-1
Robert C, Chassard C, Lawson PA, Bernalier-Donadille A (2007) Bacteroides cellulosilyticus sp. nov., a cellulolytic bacterium from the human gut microbial community. Int J Syst Evol Microbiol 57:1516–1520. https://doi.org/10.1099/IJS.0.64998-0
Rohr MW, Narasimhulu CA, Rudeski-Rohr TA, Parthasarathy S (2020) Negative effects of a high-fat diet on intestinal permeability: a review. Adv Nutr 11:77–91. https://doi.org/10.1093/ADVANCES/NMZ061
Rowan S, Jiang S, Korem T, Szymanski J, Chang ML, Szelog J, Cassalman C, Dasuri K, McGuire C, Nagai R, Du XL, Brownlee M, Rabbani N, Thornalley PJ, Baleja JD, Deik AA, Pierce KA, Scott JM, Clish CB, Smith DE, Weinberger A, Avnit-Sagi T, Lotan-Pompan M, Segal E, Taylor A (2017) Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci U S A 114:E4472–E4481. https://doi.org/10.1073/PNAS.1702302114
Rumney CJ, Duncan SH, Henderson C, Stewart CS (1995) Isolation and characteristics of a wheatbran-degrading Butyrivibrio from human faeces. Lett Appl Microbiol 20:232–236. https://doi.org/10.1111/J.1472-765X.1995.TB00435.X
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 157:107843. https://doi.org/10.1016/J.DIABRES.2019.107843
Sánchez C, Fente C, Regal P, Lamas A, Lorenzo MP (2021) Human milk oligosaccharides (HMOs) and infant microbiota: a scoping review. Foods 10. https://doi.org/10.3390/FOODS10061429
Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich Vila A, Võsa U, Mujagic Z, Masclee AAM, Jonkers DMAE, Oosting M, Joosten LAB, Netea MG, Franke L, Zhernakova A, Fu J, Wijmenga C (2019) McCarthy MI (2019) Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet 514(51):600–605. https://doi.org/10.1038/s41588-019-0350-x
Sato J, Kanazawa A, Ikeda F, Yoshihara T, Goto H, Abe H, Komiya K, Kawaguchi M, Shimizu T, Ogihara T, Tamura Y, Sakurai Y, Yamamoto R, Mita T, Fujitani Y, Fukuda H, Nomoto K, Takahashi T, Asahara T, Hirose T, Nagata S, Yamashiro Y, Watada H (2014) Gut dysbiosis and detection of “Live gut bacteria” in blood of Japanese patients with type 2 diabetes. Diabetes Care 37:2343–2350. https://doi.org/10.2337/dc13-2817
Schubert AM, Sinani H, Schloss PD (2015) Antibiotic-induced alterations of the murine gut microbiota and subsequent effects on colonization resistance against Clostridium difficile. MBio 6. https://doi.org/10.1128/mBio.00974-15
Schwab C, Gänzle M (2011) Lactic acid bacteria fermentation of human milk oligosaccharide components, human milk oligosaccharides and galactooligosaccharides. FEMS Microbiol Lett 315:141–148. https://doi.org/10.1111/J.1574-6968.2010.02185.X
Sedighi M, Razavi S, Navab-Moghadam F, Khamseh ME, Alaei-Shahmiri F, Mehrtash A, Amirmozafari N (2017) Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals. Microb Pathog 111:362–369. https://doi.org/10.1016/j.micpath.2017.08.038
Shah T, Baloch Z, Shah Z, Cui X, Xia X (2021) The intestinal microbiota: impacts of antibiotics therapy, colonization resistance, and diseases. Int J Mol Sci 22:6597. https://doi.org/10.3390/ijms22126597
Sharma S, Tripathi P (2019) Gut microbiome and type 2 diabetes: where we are and where to go? J Nutr Biochem 63:101–108. https://doi.org/10.1016/J.JNUTBIO.2018.10.003
Shen N, Dimitrova N, Ho CH, Torres PJ, Camacho FR, Cai Y, Vuyisich M, Tanton D, Banavar G (2021) Gut microbiome activity predicts risk of type 2 diabetes and metformin control in a large human cohort. medRxiv 2021.08.13.21262051. https://doi.org/10.1101/2021.08.13.21262051
Shivaji S (2019) Connect between gut microbiome and diseases of the human eye. J Biosci 44:1–5. https://doi.org/10.1007/S12038-019-9931-1
Sibley CD, Peirano G, Church DL (2012) Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology. Infect Genet Evol 12:505–521. https://doi.org/10.1016/j.meegid.2012.01.011
Sikalidis AK, Maykish A (2020) The gut microbiome and type 2 diabetes mellitus: discussing a complex relationship. Biomed 8(8):8. https://doi.org/10.3390/BIOMEDICINES8010008
Siptroth J, Moskalenko O, Krumbiegel C, Ackermann J, Koch I, Pospisil H (2023) Variation of butyrate production in the gut microbiome in type 2 diabetes patients. Int Microbiol 1–10. https://doi.org/10.1007/S10123-023-00324-6
Song MJ, Kim KH, Yoon JM, Kim JB (2006) Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 346:739–745. https://doi.org/10.1016/J.BBRC.2006.05.170
Sonkoue Lambou JC, Noubom M, Djoumsie Gomseu BE, Takougoum Marbou WJ, Tamokou JDD, Gatsing D (2022) Multidrug-resistant Escherichia coli causing urinary tract infections among controlled and uncontrolled type 2 diabetic patients at Laquintinie Hospital in Douala, Cameroon. Genet Res (Camb) 2022:. https://doi.org/10.1155/2022/1250264
St. Leger AJ, Caspi RR (2018) Visions of eye commensals: the known and the unknown about how the microbiome affects eye disease. Bioessays 40:. https://doi.org/10.1002/BIES.201800046
Stecher B, Maier L, Hardt WD (2013) “Blooming” in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol 11:277–284. https://doi.org/10.1038/nrmicro2989
Strandwitz P, Kim KH, Terekhova D, Liu JK, Sharma A, Levering J, McDonald D, Dietrich D, Ramadhar TR, Lekbua A, Mroue N, Liston C, Stewart EJ, Dubin MJ, Zengler K, Knight R, Gilbert JA, Clardy J (2018) Lewis K (2018) GABA-modulating bacteria of the human gut microbiota. Nat Microbiol 43(4):396–403. https://doi.org/10.1038/s41564-018-0307-3
Strathdee F, Free A (2013) Denaturing gradient gel electrophoresis (DGGE). Methods Mol Biol 1054:145–157. https://doi.org/10.1007/978-1-62703-565-1_9
Sugawara M, Benno Y, Koyasu E, Takeuchi M, Mitsuoka T (1991) Digestion and fermentation by human intestinal bacteria of corn fiber and its hemicellulose in vitro. Agric Biol Chem 55:565–567. https://doi.org/10.1080/00021369.1991.10870606
Suzuki T, Yoshida S, Hara H (2008) Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability. Br J Nutr 100:297–305. https://doi.org/10.1017/S0007114508888733
Takaishi H, Matsuki T, Nakazawa A, Takada T, Kado S, Asahara T, Kamada N, Sakuraba A, Yajima T, Higuchi H, Inoue N, Ogata H, Iwao Y, Nomoto K, Tanaka R, Hibi T (2008) Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol 298:463–472. https://doi.org/10.1016/j.ijmm.2007.07.016
Tanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM, Maranduca MA, Ouatu A, Floria M (2020) The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res 2020. https://doi.org/10.1155/2020/3920196
Thingholm LB, Rühlemann MC, Koch M, Fuqua B, Laucke G, Boehm R, Bang C, Franzosa EA, Hübenthal M, Rahnavard A, Frost F, Lloyd-Price J, Schirmer M, Lusis AJ, Vulpe CD, Lerch MM, Homuth G, Kacprowski T, Schmidt CO, Nöthlings U, Karlsen TH, Lieb W, Laudes M, Franke A, Huttenhower C (2019) Obese individuals with and without type 2 diabetes show different gut microbial functional capacity and composition. Cell Host Microbe 26:252-264.e10. https://doi.org/10.1016/j.chom.2019.07.004
Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474:1823–1836. https://doi.org/10.1042/BCJ20160510
Tlaskalová-Hogenová H, Tpánková R, Kozáková H, Hudcovic T, Vannucci L, Tuková L, Rossmann P, Hrní T, Kverka M, Zákostelská Z, Klimeová K, Pibylová J, Bártová J, Sanchez D, Fundová P, Borovská D, Rtková D, Zídek Z, Schwarzer M, Drastich P (2011) Funda DP (2011) The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 82(8):110–120. https://doi.org/10.1038/cmi.2010.67
Tuttolomondo A, Maida C, Pinto A (2015) Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients. J Diabetes Res 2015:. https://doi.org/10.1155/2015/268390
Tyler Patterson T, Grandhi R (2020) Gut microbiota and neurologic diseases and injuries. Adv Exp Med Biol 1238:73–91. https://doi.org/10.1007/978-981-15-2385-4_6
van Netten JJ, Bus SA, Apelqvist J, Lipsky BA, Hinchliffe RJ, Game F, Rayman G, Lazzarini PA, Forsythe RO, Peters EJG, Senneville É, Vas P, Monteiro-Soares M, Schaper NC (2020) Definitions and criteria for diabetic foot disease. Diabetes Metab Res Rev 36:e3268. https://doi.org/10.1002/DMRR.3268
Vatanen T, Kostic AD, D’Hennezel E, Siljander H, Franzosa EA, Yassour M, Kolde R, Vlamakis H, Arthur TD, Hämäläinen AM, Peet A, Tillmann V, Uibo R, Mokurov S, Dorshakova N, Ilonen J, Virtanen SM, Szabo SJ, Porter JA, Lähdesmäki H, Huttenhower C, Gevers D, Cullen TW, Knip M, Xavier RJ (2016) Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165:842–853. https://doi.org/10.1016/J.CELL.2016.04.007
Vaughn AR, Notay M, Clark AK, Sivamani RK (2017) Skin-gut axis: the relationship between intestinal bacteria and skin health. http://www.wjgnet.com/. 6:52–58. https://doi.org/10.5314/WJD.V6.I4.52
Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, Desantis TZ, Ni Z, Nguyen TH, Andersen GL (2013) Chronic kidney disease alters intestinal microbial flora. Kidney Int 83:308–315. https://doi.org/10.1038/KI.2012.345
Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat A, Louis P, McIntosh F, Johnstone AM, Lobley GE, Parkhill J (2011) Flint HJ (2010) Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 52(5):220–230. https://doi.org/10.1038/ismej.2010.118
Wang B, Yao M, Lv L, Ling Z, Li L (2017) The human microbiota in health and disease. Engineering 3:71–82. https://doi.org/10.1016/J.ENG.2017.01.008
Wang G, Liu J, Xia Y, Ai L (2021) Probiotics-based interventions for diabetes mellitus: a review. Food Biosci 43:101172. https://doi.org/10.1016/J.FBIO.2021.101172
Wei X, Guo Y, Shao C, Sun Z, Zhurina D, Liu D, Liu W, Zou D, Jiang Z, Wang X, Zhao J, Shang W, Li X, Liao X, Huang L, Riedel CU, Yuan J (2012) Fructose uptake in Bifidobacterium longum NCC2705 is mediated by an ATP-binding cassette transporter. J Biol Chem 287:357. https://doi.org/10.1074/JBC.M111.266213
Witkowski M, Weeks TL, Hazen SL (2020) Gut microbiota and cardiovascular disease. Circ Res 127:553–570. https://doi.org/10.1161/CIRCRESAHA.120.316242
Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND (2014) Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol 39:230–237. https://doi.org/10.1159/000360010
Xiao T, Zhou W (2020) The third generation sequencing: the advanced approach to genetic diseases. Transl Pediatr 9:163. https://doi.org/10.21037/TP.2020.03.06
Xiao J, Li J, Cai L, Chakrabarti S, Li X (2014) Cytokines and diabetes research. J Diabetes Res 2014. https://doi.org/10.1155/2014/920613
Yan F, Li N, Shi J, Li H, Yue Y, Jiao W, Wang N, Song Y, Huo G, Li B (2019) Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice. Food Funct 10:5804–5815. https://doi.org/10.1039/C9FO01062A
Yang JY, Lee YS, Kim Y, Lee SH, Ryu S, Fukuda S, Hase K, Yang CS, Lim HS, Kim MS, Kim HM, Ahn SH, Kwon BE, Ko HJ, Kweon MN (2017) Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice. Mucosal Immunol 10:104–116. https://doi.org/10.1038/MI.2016.42
Yao S, Zhao Z, Wang W, Liu X (2021) Bifidobacterium longum: protection against inflammatory bowel disease. J Immunol Res 2021. https://doi.org/10.1155/2021/8030297
Yazdanpanah L, Shahbazian H, Nazari I, Arti HR, Ahmadi F, Mohammadianinejad SE, Cheraghian B, Hesam S (2018) Incidence and risk factors of diabetic foot ulcer: a population-based diabetic foot cohort (ADFC study)-two-year follow-up study. Int J Endocrinol. https://doi.org/10.1155/2018/7631659
Yeoh YK, Sun Y, Ip LYT, Wang L, Chan FKL, Miao Y, Ng SC (2022) Prevotella species in the human gut is primarily comprised of Prevotella copri, Prevotella stercorea and related lineages. Sci Rep 12. https://doi.org/10.1038/S41598-022-12721-4
Ze X, Duncan SH, Louis P (2012) Flint HJ (2012) Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 68(6):1535–1543. https://doi.org/10.1038/ismej.2012.4
Zeng Q, Zhao M, Wang F, Li Y, Li H, Zheng J, Chen X, Zhao X, Ji L, Gao X, Liu C, Wang Y, Cheng S, Xu J, Pan B, Sun J, Li Y, Li D, He Y, Zheng L (2022) Integrating choline and specific intestinal microbiota to classify type 2 diabetes in adults: a machine learning based metagenomics study. Front Endocrinol (lausanne) 13:1191. https://doi.org/10.3389/FENDO.2022.906310
Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L (2013) Human gut microbiota changes reveal the progression of glucose intolerance. PLoS ONE 8:e71108. https://doi.org/10.1371/journal.pone.0071108
Zhang F, Wang M, Yang J, Xu Q, Liang C, Chen B, Zhang J, Yang Y, Wang H, Shang Y, Wang Y, Mu X, Zhu D, Zhang C, Yao M, Zhang L (2019) Response of gut microbiota in type 2 diabetes to hypoglycemic agents. Endocrine 66:485–493. https://doi.org/10.1007/S12020-019-02041-5
Zhang L, Wang Z, Zhang X, Zhao L, Chu J, Li H, Sun W, Yang C, Wang H, Dai W, Yan S, Chen X, Xu D (2022) Alterations of the gut microbiota in patients with diabetic nephropathy. Microbiol Spectr 10. https://doi.org/10.1128/SPECTRUM.00324-22
Zhao L, Lou H, Peng Y, Chen S, Zhang Y, Li X (2019) Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications. Endocrine 66:526–537. https://doi.org/10.1007/S12020-019-02103-8
Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J, Yu L, Xu C, Ren Z, Xu Y, Xu S, Shen H, Zhu X, Shi Y, Shen Q, Dong W, Liu R, Ling Y, Zeng Y, Wang X, Zhang Q, Wang J, Wang L, Wu Y, Zeng B, Wei H, Zhang M, Peng Y, Zhang C (2018) Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 80(359):1151–1156. https://doi.org/10.1126/SCIENCE.AAO5774/SUPPL_FILE/AAO5774_ZHAO_SM.PDF
Zheng D, Liwinski T (2020) Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 306(30):492–506. https://doi.org/10.1038/s41422-020-0332-7
Zheng P, Li Z, Zhou Z (2018) Gut microbiome in type 1 diabetes: a comprehensive review. Diabetes Metab Res Rev 34:e3043. https://doi.org/10.1002/DMRR.3043
Funding
This study was supported by the Ministry of Health of the Czech Republic (NU20-01-00078) and the National Institute for Research of Metabolic and Cardiovascular Diseases (EXCELES, project no. LX22NPO5104) with funding from the European Union (NextGeneration EU).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sechovcová, H., Mahayri, T.M., Mrázek, J. et al. Gut microbiota in relationship to diabetes mellitus and its late complications with a focus on diabetic foot syndrome: A review. Folia Microbiol 69, 259–282 (2024). https://doi.org/10.1007/s12223-023-01119-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-023-01119-y